List of AIDS-related topics

This is a list of AIDS-related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition. [http://www.aidsinfo.nih.gov/ed_resources/glossary/]

__NOTOC__

A

AACTG -
acquired immunity -
acquired immunodeficiency syndrome (AIDS) -
AIDSinfo -
ACT UP/Golden Gate -
active immunity -
acupuncture -
acute HIV infection -
Acute HIV Infection and Early Diseases Research Program (AIEDRP) -
ADAP -
ADC -
adenopathy -
adherence -
adjuvant -
administration -
Adult AIDS Clinical Trials Group (AACTG) -
adverse drug reaction -
aerosolized -
AETC -
agammaglobulinemia -
Agency for Healthcare Research and Quality (AHRQ) -
AHRQ -
AIDS -
AIDS dementia complex (ADC) -
AIDS Drug Assistance Programs (ADAP) -
AIDS education and training centers (AETC) -
AIDS Law Project -
AIDS research advisory committee (ARAC) -
AIDS service organization (ASO) -
The AIDS Show -
AIDS wasting syndrome -
AIDS-related cancer -
AIDS-related complex (ARC) -
aidsdrugs -
aidsline -
aidstrials -
alkaline phosphatase -
alopecia -
alpha interferon (INFa) -
alternative medicine -
alveolar -
amebiasis -
amino acids -
anaphylactic shock -
anemia -
anergy -
angiogenesis -
angiomatosis -
anorexia -
antenatal -
antibiotic -
antibodies -
antibody-dependent cell-mediated cytotoxicity (ADCC) -
antibody-mediated immunity -
antifungal -
antigen -
antigen presentation -
antigen-presenting cell (APC) -
antineoplastic -
antiprotozoal -
antiretroviral drugs -
antisense drugs -
antitoxins -
antiviral -
aphasia -
aphthous ulcer -
apoptosis -
approved drugs -
ARC -
ARM -
Armenicum -
ART -
arthralgia -
ASO -
aspergillosis -
assembly and budding -
asymptomatic -
ataxia -
attenuated -
autoantibody -
autoimmunization -
autoinoculation -
autologous -
avascular necrosis (AVN) -
AVN -

B

B cell lymphoma -
B cells -
B lymphocytes (B cells) -
bactericidal -
bacteriostatic -
bacterium -
baculovirus -
baseline -
basophil -
bDNA test -
beta-2 microglobulin (β2M) -
bilirubin -
binding antibody -
bioavailability -
biological response modifiers (BRMs) -
biopsy -
biotechnology -
blinded study -
blips -
blood-brain barrier -
body fat redistribution (BFR) syndrome -
body fluids -
bone marrow -
bone marrow suppression -
booster -
branched DNA assay -
breakthrough infection -
Broadway Cares/Equity Fights AIDS -
bronchoscopy -
budding -
buffalo hump -
bugchasing and giftgiving -
Burkitt's lymphoma -

C

C-T scan (computed tomography scan) -
cachexia -
Canadian Foundation for AIDS Research -
candida -
candidiasis -
carcinogen -
cat scan -
CBCT -
CBO -
CCR5 -
CD4 (T4) or CD4 + cells -
CDC National AIDS Hotline (CDC-NAH) -
CDC National Prevention Information Network (CDC-NPIN) -
cell lines -
cell-mediated immunity (CMI) -
cellular immunity -
Centers for Disease Control and Prevention (CDC) -
Centers for Medicare and Medicaid Services (CMS) -
central nervous system -
cerebral -
cerebrospinal fluid (CSF) -
cervical cancer -
cervical dysplasia -
cervical intraepithelial neoplasia (CIN1, CIN2, CIN3) -
cervix -
challenge (medicine) -
chancroid -
chemokines -
chemoprophylaxis -
chemotherapy -
Chlamydia -
chronic idiopathic demyelinating polyneuropathy (CIPD) -
Circumoral paresthesia -
clade -
clinical -
clinical alert -
clinical endpoint -
clinical latency -
clinical practice guidelines -
clinical trial -
clinical trials information service (aidsinfo) -
clinicaltrials.gov -
cloning -
CMS -
CMV -
CNS -
co-receptors -
coccidioidomycosis -
codon -
cofactors -
cognitive impairment -
cohort -
colitis -
combination therapy -
community planning -
Community Programs for Clinical Research on AIDS (CPCRA) -
community-based clinical trial (CBCT) -
community-based organization (CBO) -
compassionate use -
complement -
complement cascade -
complementary and alternative therapy -
complete blood count (CBC) -
computed tomography scan (C-T scan) -
concomitant drugs -
condyloma -
condyloma acuminatum -
contagious -
contraindication -
controlled trials -
core -
core protein -
correlates of immunity/correlates of protection -
CPCRA -
creatinine -
cross-resistance -
cryotherapy -
cryptococcal meningitis -
cryptococcosis -
Cryptococcus neoformans -
cryptosporidiosis -
Cryptosporidium -
CSF -
CTL -
cutaneous -
CXCR4 -
cytokines -
cytomegalovirus (CMV) -
Cytomegalovirus retinitis -
cytopenia -
cytotoxic -
cytotoxic T lymphocyte (CTL) -

D

DAIDS -
data safety and monitoring board (DSMB) -
deletion -
dementia -
demyelination -
dendrite -
dendritic cells -
deoxyribonucleic acid (DNA) -
Department of Health and Human Services (DHHS/HHS or DHHS) -
desensitization -
diabetes mellitus (DM) -
diagnosis -
diarrhea -
diplopia -
dissemination -
division of acquired immunodeficiency syndrome (DAIDS) -
DNA -
Domain (biology) -
dose-ranging study -
dose-response relationship -
double burden of disease -
double-blind study -
drug resistance -
drug-drug interaction -
DSMB -
dysplasia -
dyspnea -

E

efficacy -
empirical -
encephalitis -
end-stage disease -endemic -
endogenous -
endoscopy -
endotoxin -
endpoint -
enteric -
enteritis -
entry inhibitors -
Env -
envelope -
enzyme -
enzyme-linked immunosorbent assay (ELISA) -
eosinophil -
eosinophilic folliculitis -
epidemic -
epidemiological surveillance -
epidemiology -
epithelium -
epitope -
Epstein-Barr virus (EBV) -
erythema -
erythema multiforme -
erythrocytes -
etiology -
exclusion/inclusion criteria -
exogenous -
exotoxin -
expanded access -
experimental drug -
expression system -

F

fat redistribution -
FDA -
FDC -
floaters -
follicle -
follicular dendritic cells (FDCs) -
food and drug administration (FDA) -
functional antibody -
fungus -
fusin -
fusion inhibitor -
fusion mechanism -

G

GAG -
gamma globulin -
gamma interferon -
ganglion -
GART -
gastrointestinal (GI) -
gene -
gene therapy -
genetic engineering -
genital ulcer disease -
genital warts -
genitourinary tract -
genome -
genotypic assay -
germinal centers -
giardiasis -
globulins -
glycoprotein -
gonorrhea -
gp120 (gp120) -
gp160 (gp160) -
gp41 (gp41) -
granulocyte -
granulocyte macrophage-colony stimulating factor (GM-CSF) -
granulocyte-colony stimulating factor (G-CSF) -
granulocytopenia -

H

HAART -
hairy leukoplakia -
half-life -
HAM/TSP -
HCSUS -
Health Care Financing Administration (HCFA) -
Health Resources and Services Administration (HRSA) -
HELLP syndrome -
helper T cells -
helper/suppressor ratio (of T cells) -
hematocrit -
hematotoxic -
hemoglobin -
hemolysis -
hemophilia -
hepatic -
hepatic steatosis -
hepatitis -
hepatitis C/co-infection with HIV -
hepatomegaly -
herpes simplex virus 1 (HSV-1) -
herpes simplex virus 2 (HSV-2) -
herpes varicella zoster virus (VZV) -
herpes viruses -
highly active antiretroviral therapy (HAART) -
histocompatibility testing -
histoplasmosis -
HIV Cost and Services Utilization Study (HCSUS) -
HIV disease -
HIV prevention trials network (HPTN) -
HIV set point -
HIV vaccine trials network (HVTN) -
HIV-1 -
HIV-2 -
HIV-associated dementia -
HIV-related tuberculosis -
HLA -
Hodgkin's disease -
holistic medicine -
homology (biology) -
hormone -
host -
host factors -
HPTN -
HPV -
HRSA -
HTLV-I -
HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) -
HTLV-II -
human growth hormone (HGH) -
human immunodeficiency virus type 1 (HIV-1) -
human immunodeficiency virus type 2 (HIV-2) -
human leukocyte antigens (HLA) -
human papilloma virus (HPV) -
human T cell lymphotropic virus type I (HTLV-I) -
human T cell lymphotropic virus type II (HTLV-II) -
humoral immunity -
HVTN -
hydroxyurea -
hypergammaglobulinemia -
hyperglycemia -
hyperlipidemia -
hyperplasia -
hyperthermia -
hypogonadism -
hypothesis -
hypoxia -

I

idiopathic -
idiopathic thrombocytopenia purpura -
IHS -
immune complex -
immune deficiency/immunodeficiency -
immune response -
immune system -
immune thrombocytopenic purpura -
immunity -
immunization -
immunocompetent -
immunocompromised -
immunodeficiency -
immunogen -
immunogenicity -
immunoglobulin (Ig) -
immunoglobulin A (IgA) -
immunoglobulin D (IGD) -
immunoglobulin E (IGE) -
immunoglobulin G (IGG) -
immunoglobulin M (IGM) -
immunomodulator -
immunostimulant -
immunosuppression -
immunotherapy -
immunotoxin -
in vitro -
in vivo -
incidence -
inclusion/exclusion criteria -
Incubation period -
IND -
Indian Health Service (IHS) -
infection -
infectious -
informed consent -
infusion -
inoculation -
institutional review board (IRB) -
integrase -
integrase inhibitors -
integration -
intensification -
intent to treat -
interaction -
interferon -
interleukin-1 (IL-1) -
interleukin-2 (IL-2) -
interleukin-4 (IL-4) -
interleukin-12 (IL-12) -
interleukins -
International Center for Research on Women -
interstitial -
intramuscular (IM) -
intrapartum -
intravenous -
intravenous immunoglobulin (IVIG) -
intravitreal -
Investigational New Drug (IND) -
IRB -
isolate -
ITP -
IVIG -

J

jaundice -
JC virus -

K

Kaposi's sarcoma (KS) -
Karnofsky score -
killer T cells -
KSHV -
Kupffer cells -

L

LAI -
Langerhans cells -
LAS -
lentivirus -
lesion -
leukocytes -
leukocytosis -
leukopenia -
leukoplakia -
LFT -
LIP -
lipid -
lipodystrophy -
liposomes -
live vector vaccine -
liver function test (LFT) -
LOG -
long terminal repeat sequence (LTR) -
long-term nonprogressors -
LTR -
lumbar -
lumbar puncture -
lymph -
lymph nodes -
lymphadenopathy syndrome (LAS) -
lymphatic vessels -
lymphocyte -
lymphoid interstitial pneumonitis (LIP) -
lymphoid organs -
lymphoid tissue -
lymphokine-activated killer cells (LAK) -
lymphokines -
lymphoma -
lymphopenia -
lymphoproliferative response -
lysis -

M

MAC -
macrophage -
macrophage-tropic virus -
magnetic resonance imaging (MRI) -
MAI -
maintenance therapy -
major histocompatibility complex (MHC) -
malabsorption syndrome -
malaise -
malignant -
mast cell -
MedlinePlus -
mega-HAART -
memory T cells -
meninges -
meningitis -
messenger RNA -
metabolism -
metastasis -
MHC -
microbes -
microbicide -
Microsporidiosis -
mitochondria -
mitochondrial toxicity -
molecule -
molluscum contagiosum -
monocyte -
mononeuritis multiplex (MM) -
monovalent vaccine -
morbidity -
MRI -
mucocutaneous -
mucosa -
mucosal immunity -
mucous membrane -
multi-drug rescue therapy -
multiple drug-resistant tuberculosis (MDR-TB) -
mutation -
myalgia -
mycobacterium -
mycobacterium avium complex (MAC) -
mycosis -
myelin -
myelopathy -
myelosuppression -
myelotoxic -
myocardial -
myopathy -

N

NADIR -
NAT -
National AIDS Hotline -
National Cancer Institute (NCI) -
National Institute of Allergy and Infectious Diseases (NIAID) -
National Institute of Child Health and Human Development (NICHD) -
National Institutes of Health (NIH) -
National Library of Medicine (NLM) -
National Prevention Information Network (NPIN) -
natural history study -
natural killer cells (NK cells) -
NCI -
New Drug Application -
nebulized -
Nef -
neonatal -
neoplasm -
nephrotoxic -
neuralgia -
neurological complications of AIDS -
neuropathy -
neutralization -
neutralizing antibody -
neutralizing domain -
neutropenia -
neutrophil -
New Drug Application (NDA) -
New York Cares -
NIAID -
NICHD -
night sweat -
NIH -
NK cell -
NLM -
NNRTI -
non-Hodgkin's lymphoma (NHL) -
non-nucleoside reverse transcriptase inhibitors (NNRTI) -
non-steroidal anti-inflammatory drugs (NSAID) -
NRTI -
nucleic acid -
nucleic acid test -
nucleocapsid -
nucleoli -
nucleoside -
nucleoside analog -
nucleoside reverse transcriptase inhibitors (NRTI) -
nucleotide -
nucleotide analogs -
nucleus -
null cell -

O

ocular -
off-label use -
Office of AIDS Research (OAR) -
OI -
oncology -
open-label trial -
opportunistic infections -
oral hairy leukoplakia (OHL) -
organelle -
oropharyngeal -
orphan drugs -
osteonecrosis -
osteopenia -

P

P24 -
package insert -
palliative -
palliative care -
pancreas -
pancreatitis -
pancytopenia -
pandemic -
pap smear -
papilloma -
parallel track -
parasite -
parenteral -
paresthesia -
passive immunity -
passive immunotherapy -
pathogen -
pathogenesis -
PBMC -
PCP -
PCR -
Pediatric AIDS Clinical Trial Group (PACTG) -
pelvic inflammatory disease -
peptide -
perianal -
perinatal -
perinatal transmission -
peripheral neuritis -
peripheral neuropathy -
persistent generalized lymphadenopathy -
person with AIDS (PWA) -
PGL -
phagocyte -
phagocytosis -
pharmacokinetics -
phase I trials -
phase II trials -
phase III trials -
phase IV trials -
phenotypic assay -
photosensitivity -
PHS -
pituitary gland -
placebo -
placebo controlled study -
placebo effect -
plasma -
plasma cells -
platelets -
PML -
Pneumocystis jiroveci pneumonia (formerly Pneumocystis carinii or PCP) -
POL -
polymerase -
Polymerase chain reaction (PCR) -
polyneuritis -
polypeptide -
polyvalent vaccine -
post-exposure prophylaxis (PEP) -
PPD test -
pre-conception counseling -
preclinical -
precursor cells -
prevalence -
primary HIV infection -
primary isolate -
primaquine -
proctitis -
prodrome -
prodrug -
progressive multifocal leukoencephalopathy (PML) -
prophylactic drug -
prophylaxis -
protease -
protease inhibitors -
protease-sparing regimen -
proteins -
protocol -
protozoa -
provirus -
pruritus -
pseudo-Cushing's syndrome -
pseudovirion -
PUBMED -
pulmonary -
purified protein derivative (PPD) -

R

radiology -
randomized trial -
rebound -
receptor (immunology) -
recombinant -
recombinant DNA -
recombinant DNA technology -
refractory (medicine) -
regulatory genes -
regulatory T cells -
remission -
renal -
rescue therapy -
resistance -
resistance testing -
retina -
retinal detachment -
retinitis -
retrovirus -
REV -
reverse transcriptase -
ribonucleic acid (RNA) -
ribosome -
RNA -
route of administration -
RT-PCR -
RTI -
Ryan White C.A.R.E. act -

S

safe sex -
safer sex -
salmonella -
salvage therapy -
SAMHSA -
sarcoma -
seborrheic dermatitis -
secondary prophylaxis -
sepsis -
seroconversion -
serologic test -
seroprevalence -
serosorting --
serostatus -
serum -
serum glutamic oxaloacetic transaminase (SGOT) -
serum glutamic pyruvate transaminase (SGPT) -
set point -
sexually transmitted disease (STD) -
shingles -
SHIV -
side effects -
simian immunodeficiency virus (SIV) -
sinusitis -
SIT -
SIV -
Special Projects of National Significance (SPNS) -
spinal tap -
spleen -
splenomegaly -
sputum analysis -
standard of care -
staphylococcus -
STD -
stem cells (FDCs) -
steroid -
Stevens-Johnson syndrome -
STI -
stomatitis -
strain -
stratification -
structured intermittent therapy (SIT) -
structured treatment interruption (STI) -
study endpoint -
subarachnoid space -
subclinical infection -
subcutaneous (SQ) -
Substance Abuse and Mental Health Services Administration (SAMHSA) -
subunit HIV vaccine -
sulfa drug -
sulfonamides -
superantigen -
suppressor T cell -
surrogate marker -
surveillance -
susceptible -
symptoms -
syncytium -
syndrome -
synergism -
synergistic -
synthesis -
syphilis -
systemic -

T

T cells (T lymphocytes) -
T lymphocyte proliferation assay -
T lymphocytes -
T suppressor cells -
T4 cell -
T4 cells (T-helper cells) -
T8 cells -
Tanner staging -
TAT -
TB -
template -
teratogenicity -
Terry Beirn Community Programs for Clinical Research on AIDS -
testosterone -
therapeutic HIV vaccine -
thrombocytopenia -
thrush -
thymosin -
thymus -
tissue -
titer -
toxicity -
toxoplasmic encephalitis -
toxoplasmosis -
transaminase -
transcription -
transfusion -
translation -
transmission -
transplacental -
treatment IND -
triglycerides -
tuberculin skin test (TST) -
tuberculosis (TB) -
tumor necrosis factor (TNF) -

V

V3 loop -
vaccination -
vaccine -
vaccinia -
vaginal candidiasis -
valley fever -
variable region -
varicella zoster virus (VZV) -
vector -
vertical transmission -
viral burden -
viral core -
viral culture -
viral envelope -
viral load -
viremia -
viricide -
virion -
virology -
virus -
visceral -

W

wasting syndrome -
Western blot -
white blood cells -
wild-type virus -
window period -
Women's Interagency HIV Study (WIHS) -

Y

yeast infection -

Z

zinc finger inhibitor -
zinc fingers -